Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Overactive bladder in special patient populations.

Rodney A Appell

    Reviews in Urology
    |September 21, 2006
    PubMed
    Summary

    Antimuscarinic agents are common overactive bladder (OAB) treatments, but their use in specific patient groups requires careful consideration due to potential side effects. This review examines OAB management in pediatric, geriatric, pregnant, and neurogenic populations.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Helping Incontinent Patients Resume Activity.

    The Physician and sportsmedicine·2017
    Same author

    Urethral and bladder injections for incontinence including botox.

    The Urologic clinics of North America·2011
    Same author

    Solifenacin for overactive bladder: secondary analysis of data from VENUS based on baseline continence status.

    International urogynecology journal·2010
    Same author

    Update of AUA guideline on the surgical management of female stress urinary incontinence.

    The Journal of urology·2010
    Same author

    Oxybutynin and its new transdermal application for the treatment of overactive bladder.

    Women's health (London, England)·2009
    Same author

    Nonsurgical transurethral radiofrequency treatment of stress urinary incontinence in women.

    Women's health (London, England)·2009

    Area of Science:

    • Urology
    • Pharmacology
    • Patient Care

    Background:

    • Overactive bladder (OAB) significantly impairs quality of life for many individuals.
    • Antimuscarinic agents are the primary pharmacological treatment for OAB.
    • Concerns exist regarding the safety and efficacy of antimuscarinics in specific patient demographics.

    Purpose of the Study:

    • To review the use of antimuscarinic agents in specific OAB patient populations.
    • To discuss current knowledge on antimuscarinic therapy in pediatric, geriatric, pregnant, men with prostate issues, and neurogenic OAB patients.

    Main Methods:

    • Literature review of existing studies and clinical guidelines.
    • Analysis of adverse events and side effect profiles in distinct patient groups.
    • Synthesis of current understanding regarding antimuscarinic use in vulnerable populations.

    Main Results:

    • Antimuscarinic use is limited in certain OAB populations due to potential adverse events.
    • Specific concerns include pediatric, geriatric, pregnant, and neurogenic OAB patients.
    • Data on efficacy and safety in these groups are still evolving.

    Conclusions:

    • Physicians must carefully weigh the benefits and risks of antimuscarinics in specific OAB patient groups.
    • Further research is needed to optimize antimuscarinic therapy for pediatric, geriatric, pregnant, and neurogenic OAB.
    • Individualized treatment approaches are crucial for managing OAB in diverse patient populations.

    Related Experiment Videos